Miguel Biscaia

Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood

Miguel Biscaia, Susana Marín, Beatriz Martín‐Fernández et al. · Psychopharmacology · 2003 · 140 citations

Behavioral Sciences, Behavioral Neuroscience, Addiction +8

Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats

Eva M. Marco, Miguel Biscaia, Beatriz Martín‐Fernández et al. · Pharmacology Biochemistry and Behavior · 2003 · 77 citations

Molecular Pharmacology, Anxiogenic-like Effect, Addiction +13

Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system

Miguel Biscaia, Beatriz Martín‐Fernández, Alejandro Higuera‐Matas et al. · Neuropharmacology · 2008 · 71 citations

Opioid Epidemic, Cannabis Use, Substance Abuse +13

Synthetic Studies of Neoclerodane Diterpenes from <i>Salvia divinorum:</i> Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability

Rachel Saylor Crowley, Andrew P. Riley, Alexander M. Sherwood et al. · Journal of Medicinal Chemistry · 2016 · 50 citations · Full text

Transcription of the pain‐related TRPV1 gene requires Runx1 and C/EBPβ factors

Giorgia D. Ugarte, Emilio Moyano-Dí­az, Miguel Biscaia et al. · Journal of Cellular Physiology · 2012 · 24 citations · Full text

Environmental Signaling, Molecular Regulation, Synaptic Transmission +24